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DNA interstrand cross-links (ICLs) are critical cytotoxic lesions produced by cancer chemotherapeutic agents such as the
nitrogen mustards and platinum drugs; however, the exact mechanism of ICL-induced cell death is unclear. Here, we show a
novel mechanism of p53-independent apoptotic cell death involving prolonged cell-cycle (G2) arrest, ICL repair involving HR,
transient mitosis, incomplete cytokinesis, and gross chromosomal abnormalities resulting from ICLs in mammalian cells.
This characteristic ‘giant’ cell death, observed by using time-lapse video microscopy, was reduced in ICL repair ERCC1- and
XRCC3-deﬁcient cells. Collectively, the results illustrate the coordination of ICL-induced cellular responses, including cell-cycle
arrest, DNA damage repair, and cell death.
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DNA interstrand cross-linking agents such as the nitrogen
mustards, platinum drugs, chloroethylnitrosoureas, alkyl-
alkanesuphonates, and the natural product mitomycin-C
are still widely used in cancer chemotherapy.
1 Bifunctional
covalent modiﬁcation of DNA (cross-linking) is essential
for antitumour activity as monofunctional analogues are
generally inactive.
2 Cross-links can be formed on the same
strand of DNA (intrastrand), between the opposite strands
of DNA (interstrand), or between DNA and a reactive
protein (DNA–protein).
3 Among these, interstrand cross-links
(ICLs), which normally account for a small proportion
(1–10%) of total adducts, are critical for cytotoxicity
4,5
and also, if unrepaired, the efﬁcacy of treatment
6–8 by
preventing any process requiring the separation of the DNA
strands.
9
Clinical inherent sensitivity of tumours to ICL agents may
result from a defect in recognition or repair, and enhanced
repaircanresultinclinicalacquiredresistance,
6,7althoughthe
precise mechanism of ICL repair in mammalian cells has still
to be fully elucidated.
3,10 Extensive genetic and biochemical
studies suggest that ICL repair involves the initial incision
and ‘unhooking’ of ICLs by Mus81-Eme1 and XPF-ERCC1
endonucleases,
11 and subsequent processing by homo-
logous recombination (HR)
2 and translesion synthesis
12
involving XRCC2, XRCC3, WRN, BRCA2, Fanconi anaemia
(FA),
13–15 and DNA pol-z
16 depending on the phase of the cell
cycle.
17
As an ICL can lead to a stalled replication fork in S-phase,
9
ICL damaged cells likely activate cell-cycle checkpoint and
arrestat lateS to G2
18 to attempt to repair theDNA damage.
19
The cellular fate after the ICL-induced G2 arrest is, however,
poorly understood. Cells can continuously arrest or die in
G2.
20 Alternatively, cells may progress through G2 with the
induction of cell death in mitosis,
21 or the subsequent G1 or S
phase.
12 The detailed mechanism and timing of ICL-induced
cell death are still to be elucidated.
Cell death has an important role in the elimination of
damaged cells. Necrosis and apoptosis are often observed
following extensive DNA damage. While necrosis character-
istically results in cell swelling and plasma membrane rupture,
apoptosis produces nuclear condensation, cell shrinkage,
loss of cell–cell or cell–substrate contact,
22 mitochondrial
release of cytochrome-c, and activation of caspase cascades
leading to DNA fragmentation.
23 Apoptotic-like G2
20 and
mitotic cell death, which is linked to abnormal chromosomal
segregation and failure of mitosis,
21 are observed following
mitotic-disrupting drugs. Escaping cell death at G2/M may
result in tetraploidy
24 or polyploidy.
25
The aimofthis study wasto elucidatethe mechanism ofcell
death resulting from ICL by the clinically used nitrogen
mustard mechlorethamine (HN2). This is evaluated in relation
to cell-cycle response and repair of ICL damage using
DNA-repair-deﬁcient Chinese hamster ovary (CHO) cell lines
and human cervix carcinoma (HeLa) cells. The fate of cells
following ICL damage is investigated by using time-lapse
video microscopy. Collectively, these studies show the
coordination of ICL-induced cell-cycle arrest, DNA damage
repair, and cell death. Our data more fully deﬁne the
mechanism of ICL-induced cell death following cell-cycle
arrest and failure of ICL repair.
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DNA ICLs induce cell death associated with prolonged
G2 cell-cycle arrest. DNA ICLs are critical cytotoxic
lesions, and the number of ICLs formed increases with the
concentration of bifunctional ICL agents (Supplementary
Figure S1).
2,26 To investigate the relationship between cyto-
toxicity and cell-cycle response resulting from ICL formation,
we performed clonogenic cell survival and cell-cycle
analyses in wild-type CHO (AA8) cells after exposure to
HN2 for 1h. A dose-dependent decrease in cell survival
was observed, with an LD50 (lethal dose, 50%) of 5mM
(Figure 1a). Moreover, a dose-dependent induction of G2
arrest at 12h was observed in AA8 cells following exposure
to HN2 (Figure 1b).
To examine induction and prolongation of G2 arrest,
we performed phase-dependent cell-cycle analysis in bromo-
deoxyuridine (BrdU) pulse-labelled cells by using ﬂow
cytometry following 10mM (LD80) HN2 treatment (Figure 1c).
It was observed that cells treated with HN2 during any phase
of the cell cycle were subsequently arrested in G2 and this
persisted for up to 48h. HN2 treatment of cells in G1, S, and
G2 induced G2 arrest but at different time points (Figure 1c).
HN2-treated cells in G1 progressed through S-phase and
were subsequently arrested in G2 by 24h, which persisted
up to 48h. Cells treated in S-phase (Figure 1c, bottom) were
also arrested at the subsequent G2 phase as early as 12h
after treatment and persisted up to 48h. Interestingly, the
percentage of G2 cells relative to G1 cells in BrdU-negative
cell fractions at 0h (19.4%) was slightly decreased at 6h
(16.8%) as compared with a signiﬁcant increase at later time
points (66.59% at 12h, 90.58% at 24h, and 81.9% at 48h).
This may indicate that cells in G2 at the time of HN2 treatment
were not arrested in this phase and either completed the
ﬁrst cytokinesis or underwent cell death (Figure 1c and
Supplementary Figure S2).
TodetermineanydifferenceinsensitivitytoICLsdepending
on the cell-cycle phases, we performed Hoechst-33342
Figure 1 HN2-inducedcelldeathassociatedwithprolongedG2cell-cyclearrest.(a)HN2concentration-dependentinductionofcelldeath.Percentagecellsurvivalofwild-
type CHO (AA8) cells treated with HN2 as determined by clonogenic assay. The data are represented as mean±S.E.M. (b) HN2 concentration-dependent induction of G2
cell-cycle arrest. Cell-cycle histograms (DNA content versus cell count) of AA8 cells treated with HN2 (10mM) were acquired by ﬂow-cytometric analysis. Cells that had
undergoneapoptosisandproducedasub-G1population(ﬂoatingcells)wereexcludedfromthisanalysis.(c)MaintenanceofG2arrestinAA8cellstreatedwithHN2.BrdUcell-
cycleanalysisof AA8cellstreatedwithHN2(10mM).Thedotplotsrepresent incorporationofBrdU(y-axis)againstDNA content(x-axis)of untreatedcontrolandHN2-treated
cells. BrdU-positivecellswere gated andtheir DNAproﬁles are shown. Floatingcells were excludedfrom this analysis.(d) Differencein sensitivityto HN2 betweencells in the
G1andG2 phasesofthecellcycle.Hoechst-33342-stainedliveG1andG2 cellsweresortedaccordingto DNAcontentbyusingaFACS Vantagecellsorter(BDBioSciences).
After HN2 treatment, subsequent clonogenic cell survival of G1 and G2 cells was determined. The data are presented as mean±S.E.M.
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Cell Death and Diseasestaining and live cells were sorted into G1 and late-S/G2
phases on the basis of their DNA proﬁle at the time of HN2
treatment. Cells in late-S/G2 were approximately two-fold
more resistant to HN2 than cells in G1 (Figure 1d), which
suggests that the G1 cells died after the ﬁrst S-phase because
of the cytotoxicity induced as a result of attempted replication
of cross-linked DNA. This may imply a failure to block cell-
cycle progression even with unresolved DNA synthesis. By
contrast, cells in G2 do not replicate their DNA until after
division and therefore twice as many cells may contribute to
the two-fold higher resistance of G2 cells to HN2.
Cellular fate following ICL damage. To investigate the
fate of cells following ICL-induced G2 arrest, HN2-treated
(10mM) AA8 cells were observed for 72h by time-lapse
video microscopy (Figure 2). The number of HN2-treated
cells was decreased by 72h, indicating both suppression of
cell division and induction of cell death (Supplementary
Figure S3). Most of the HN2-treated cells (490%) showed
‘giant’ cell formation. The HN2-treated cells did not undergo
cell death in G2. Instead, they underwent pseudo-division
(incomplete cytokinesis) after entry into a transient mitosis,
which resulted in tetraploid (4n)G 1 cell death associated with
multinucleated DNA (Figure 2a). Remarkably, some giant
cells progressed through mitosis and were capable of
attempted cell division into two daughter cells. However,
this cytokinesis was only temporary because both daughter
cells were fused together and became a multinucleated,
Figure 2 Cell fate following ICL damage. (a) HN2-induced giant cell death following prolonged G2 arrest. Most of the 10-mM HN2-treated AA8 cells (red arrow) entered
transient mitosis associated with incomplete cytokinesis (43h to 45h 55min) and developed into giant cells containing polyploid nuclei (47h 20min to 56h 20min). This was
followed by tetraploid G1 cell death (57h 20min to 62h 30min) as observed by time-lapse video microscopy. (b) HN2-induced giant cell death associated with fusion of two
daughter cells. Some HN2-treated AA8 cells completed cytokinesis (43h 25min to 44h 20min) followed by cell fusion (49h 30min to 50h 15min) and consequently died in
thetetraploidG1phase(50h 50minto 54h10min) asobservedbytime-lapsevideomicroscopy.(c) HN2-treated H2B-GFP-expressingcellsformedmultinucleated tetraploid
G1 cells following incomplete cytokinesis. Phase-contrast and/or epiﬂuorescence images of HN2 (10mM)-treated H2B-GFP AA8 cells observed by ﬂuorescence video
microscopy showing giant cell formation (0h to 64h 45min), transient mitosis (65h 35min), exit from mitosis associated with incomplete cytokinesis (67h 30min to 68h
20min), and consequent formation of multinucleated tetraploid G1 cells (68h 45min to 71h 55min)
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Cell Death and Diseasetetraploid G1 cell, which consequently resulted in tetraploid
G1 cell death (Figure 2b).
For a detailed observation of the chromosome dynamics
during HN2-induced incomplete cytokinesis, we generated
histone-H2B-GFP-expressing AA8 cells and continuously
observed them by ﬂuorescence video microscopy. HN2-
treated cells demonstrated the formation of giant cells
associated with an increase in the size of the interphase
nucleus, chromosomal condensation, and transient mitosis
without any evidence of proper metaphase chromosome
alignment at the equator of the spindle (Figure 2c) compared
with untreated control cells (Supplementary Figure S4).
Thereafter, the HN2-treatedcells exitedfrom transient mitosis
without showing proper anaphase characterised by synchro-
nous chromatid separation; instead, small multi-nuclei and
multinucleated G1 cells were formed after incomplete
cytokinesis (Figure 2c). Therefore, after prolonged G2 arrest,
the ICL-damaged cells underwent tetraploid G1 cell death
associated with incomplete cytokinesis.
ICL induces apoptosis after prolonged G2 arrest. We
next investigated the mechanism and the timing of giant cell
death. Phosphatidylserine (PS) cell membrane externalisa-
tion, mitochondrial permeablisation, and activation of
caspases were examined as typical features of apoptosis. In
response to a 1-h HN2 treatment (10mM), the number of
apoptotic (Annexin-V-positive and PI
Low) and dead (Annexin-
V-positive and PI
High) cells were signiﬁcantly increased
between 24 and 72h (Figures 3a–c). We then examined
mitochondrial permeablisation by a decrease in LDS-751
intensity concomitant with a collapse in mitochondrial mem-
brane potential. In agreement, the AA8 cells showed mito-
chondrial potential change (LDS-751
Low and TO-PRO-3
Low
cells) and cell death associated with mitochondrial membrane
potential collapse (LDS-751
Low and TO-PRO-3
High cells)
between 24 and 72h following HN2 treatment (Figures 3d–f).
Moreover, activation of caspase-3 was detected at 48h
following HN2 treatment (Figures 4a and b).
27 Together,
these results suggest that cell death was associated with the
typical morphological and biochemical features of apoptosis.
To examine ICL-induced cell death and cell-cycle proﬁles,
sub-G1 analysis was conducted following equitoxic mono-
functional (HN1) and bifunctional (HN2) nitrogen mustard
treatment. HN1 can extensively alkylate cellular DNA but can
only produce monoadducts and only shows cytotoxicity at
very high concentrations compared with bifunctional HN2 (the
LD80 were 1000 and 10mM for HN1 and HN2, respectively
2).
Although both HN1 and HN2 induced signiﬁcant increases in
the sub-G1 cells starting at 24h following LD80 treatments, the
cell-cycle responses between HN1- and HN2-treated cells
were distinct (Figures 4c–f). The HN1-treated samples
showed an accumulation of sub-G1 cells in non-phase-
speciﬁc DNA fragmentation without induction of signiﬁcant
G2 arrest (Figure 4d). By contrast, the HN2-treated samples
showed an accumulation of sub-G1 cells following G2 arrest
with tetraploid (4n) DNA (Figure 4e). Taken together, these
data suggest that apoptosis was induced following prolonged
G2 arrest in an ICL-induced tetraploid G1 state.
Figure 3 ICL-induced cell membrane externalisation and mitochondrial potential changes. PS cell membrane externalisation (Annexin-V versus PI staining) increases
from 24h in AA8 cells: Typical proﬁles of Annexin-V versus PI: Untreated control AA8 cells at 24h (a) and HN2 (10mM)-treated AA8 cells at 48h (b) as measured by ﬂow
cytometry.Thegraphinpanelcshowsthepercentagesofcommittedcelldeathbetween24and72hafterHN2(10mM)treatment.ThefractionofAnnexin-V-positivecells(%)
was normalised by subtracting the number of dead cells from the number of untreated control cells. Floating cells were included in this analysis. Mitochondrial potential
changes (TO-PRO-3 versus LDS-751) increase from 24h in AA8 cells: Typical proﬁles of LDS-751 versus TO-PRO-3: Untreated control AA8 cells at 24h (d) and HN2
(10mM)-treated AA8 cells at 72h (e) as measured by ﬂow cytometry. The graph in panel f shows the percentages of committed cell death between 24 and 72h after HN2
(10mM) treatment in AA8 cells. The fraction of LDS-751
Low cells (%) was normalised by subtracting the number of dead cells from the number of untreated control cells.
Floating cells were included in this analysis
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Cell Death and DiseaseGiant cells induce p53-independent apoptosis with
chromosomal abnormalities. We examined interphase
nuclei and metaphase chromosomes in HN2-treated AA8
cells during transient mitosis. We observed an enlargement
of interphase nuclei and increased chromosomal aberrations
such as chromosome crossing-over and ring structures at
48h after HN2 treatment as compared with untreated control
cells (Figure 5a). Further enlargement of the interphase
nuclei and chromosomal ampliﬁcation were observed at
72h. Inhibition of cytokinesis has been reported following
X-irradiation,
28,29 thus cells may override G2 the damage
checkpoint following ICL damage, which may have resulted
in chromosomal abnormalities and tetraploid G1 cell death
associated with incomplete cytokinesis. This result also
suggests that excess ICL-repair processing, such as by HR
repair, participates in the formation of abnormal chromo-
somes and ICL-induced cell death.
p53 has been shown to be required for apoptotic cell death
induced by various DNA damage.
19 To investigate whether
the tetraploid G1 apoptosis triggered by gross chromosomal
abnormalities resulting from ICL is p53-dependent, we
examined the apoptotic proﬁles of AA8 cells transfected with
dominant-negative p53 (dn-p53)
30 following HN2 treatment.
Overexpression of dn-p53 did not affect the percentage of
apoptotic and dead cells, as determined by Annexin-V
(Figure 5b, left) and sub-G1 (Figure 5b, right) analysis.
Because overexpression of dn-p53 can inhibit p53-family
members (p53, p63, p73),
31 these results suggest that the
ICL-induced tetraploid G1 cell death observed in AA8 cells is
independent of p53.
To investigate whether ICL induces giant cell death in a
human cancer cell, we analysed HN1- and HN2-treated
HeLa cells. The HeLa cells were sensitive to HN2, with an
approximate 100-fold increased sensitivity over mono-
functional HN1 (Figure 5c). Both HN1 and HN2 induced
typical apoptosis in HeLa cells following exposure to
equitoxic concentrations (90% growth inhibition, GI90)o f
these agents, as determined by ﬂuorescence video micro-
scopy and sub-G1 analysis (Supplementary Figure S5 and
Supplementary Figure S6). Lower concentrations (GI50)o f
HN2-treated, H2B-GFP-expressing HeLa cells showed the
formation of giant cells with enlarged nuclei and, conse-
quently, giant cell death (Figure 5d). Cell-cycle histograms
showed increasing sub-G1 peaks from 24h after HN2 (GI50)
treatment following tetraploid (4n) and octaploid (8n) states
(Figure 5e).
ICL repair increases G2 arrest and chromosomal
abnormalities following HN2 treatment. We investigated
whether failure of ICL repair contributes to prolongation
of G2 arrest, gross chromosomal abnormalities, and cell
death. Equitoxic doses (LD80) of HN2 were determined to be
10, 0.8, and 0.3mM for XPG (UV135)-, ERCC1 (UV96)-, and
XRCC3 (irs1SF)-deﬁcient cells, respectively (Figure 6a).
When LD50 values were compared, XRCC3- and ERCC1-
deﬁcient cells were, respectively, 63- and 16-fold more
sensitive to HN2 than their isogenic parent (AA8) cells,
indicating the crucial role of HR and ERCC1 in the repair of
HN2-induced DNA damage as shown previously.
2,13 By
contrast, the XPG-deﬁcient cells showed similar sensitivity to
AA8 cells, suggesting that this NER protein does not have
a signiﬁcant role in the repair of HN2-induced ICL lesions.
To determine the mechanism of ICL-induced cell death
in the repair-deﬁcient cells, we performed membrane and
organelle analyses in XPG-, ERCC1-, and XRCC3-deﬁcient,
HN2-treated cells. We observed HN2-induced apoptosis
between 24 and 72h in these cell lines, along with increased
PS membrane externalisation and mitochondrial permeabli-
sation (Supplementary Figure S7). We then simultaneously
examined apoptosis and cell-cycle arrest in ERCC1- and
XRCC3-deﬁcient cells following exposure to equitoxic con-
centrations of HN2 by sub-G1 analysis. In agreement with
the membrane and organelle analyses, both ERCC1- and
XRCC3-deﬁcient cells showed an increased number of
Figure 4 ICL-induced apoptosis after prolonged G2 arrest. HN2 activates caspase-3 in AA8 cells: Activation of caspase-3 was measured in untreated control AA8 cells
(a) and HN2 (10mM)-treated AA8 cells (b) at the indicated time points after treatment. Fragmentation of DNA is associated with prolonged G2 arrest in cells treated with
bifunctionalHN2(LD80¼10mM)butnotmonofunctionalHN1(LD80¼1000mM)atequitoxicconcentrations:Sub-G1cell-cycleproﬁlesofuntreatedcontrolAA8cells(c),HN1-
treatedAA8cells(d),andHN2-treatedAA8cells(e).Thefractionofcellsinsub-G1(%)wasplottedagainsttimeaftertreatment(f).Floatingcellswereincludedinthisanalysis
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Cell Death and Diseasesub-G1 cells between 24 and 72h (Figure 6b); however, G2
arrestwasonly transiently induced anddid notpersist in these
cells (Supplementary Figure S8), in contrast to the wild-type
cells (Figure 4e).
To investigate the fate of ICL-repair-deﬁcient cells, we
generated H2B-GFP-expressing irs1SF cells and observed
them for 72h by ﬂuorescence video microscopy following
equitoxic HN2 treatment. XRCC3-deﬁcient cells did not show
giant cell death, but cell death after cell division, followed by
relatively normal chromosomal segregation compared with
AA8 cells in response to equitoxic HN2 treatment (Figure 6c).
Incomplete cytokinesis, which was a critical step in the
formation of ICL-induced, tetraploid, multinucleated giant
cells in wild-type cells (Figure 2), was attenuated in XRCC3-
deﬁcient cells. The percentage of incomplete cytokinesis
relativetothenumberofnormalcell divisionswassigniﬁcantly
decreased in XRCC3-deﬁcient cells as compared with the
wild-type cells, as determined by a cell-tracking system
Figure 5 p53-independent apoptosis of giant cells induced by chromosomal abnormalities. (a) ICL induces chromosomal aberrations in AA8 cells. Inverted ﬂuorescence
images of DAPI-stained giant interphase nucleus and abnormal metaphase chromosomes of untreated and HN2-treated (10mM) AA8 cells at 48 and 72h. Images were
captured at the same magniﬁcation (objective, 100 10). (b) ICL induces p53-independent tetraploid G1 cell death in AA8 cells. Apoptotic Annexin-V-positive cells (left)
and sub-G1 cells (right) in HN2 (10mM)-treated vector control (vehicle) or dn-p53
175 (dn-p53)-overexpressing AA8 cells. The data are presented as the means±S.E.M.
(c)HypersensitivityofHeLacellstobifunctionalHN2ascomparedwithmonofunctionalHN1.Thedataarepresentedasthemean±S.E.M.(d)HN2inducesgiantcelldeathin
HeLa cells. HN2 (1mM)-treated H2B-GFP-expressing HeLa cells underwent giant cell death as observed by ﬂuorescence video microscopy. (e) HN2-induced tetra/octaploid
cell death in HeLa cells. The sub-G1 cell-cycle proﬁles of untreated cells, HN2 (1mM)-treated cells (including both ﬂoating and adherent cells), HN2 (1mM)-treated adherent
cells, and HN2 (1mM)-treated ﬂoating cells
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Cell Death and DiseaseFigure 6 Cell death associated with decreased chromosomal abnormalities and less prolongation of G2 arrest in ICL-repair-deﬁcient cells following equitoxic HN2
treatment. (a) Hypersensitivity of ERCC1- and XRCC3-defective cells to HN2. Percentage cell survival of wild-type (AA8), XPG-deﬁcient (UV135), ERCC1-deﬁcient (UV96),
and XRCC3-deﬁcient (irs1SF) cell lines exposed to HN2 as determined by clonogenic assay. The data are presented as the mean±S.E.M. (b) Induction of cell death
associated with decrease in G2 arrest in ERCC1- and XRCC3-deﬁcient cells following equitoxic HN2 treatment. The sub-G1 cell-cycle proﬁles of untreated and HN2-treated
ERCC1-deﬁcient(0.8mM)andXRCC3-deﬁcientcells(0.3mM).Floatingcellswereincludedinthisanalysis.(c)HN2-treatedXRCC3-deﬁcientcellsinducedcelldeathfollowing
cell division without enlargement of cells. Phase-contrast and/or epiﬂuorescence images of H2B-GFP-expressing irs1SF cells treated with HN2 (LD80¼0.3mM) showing
interphaseat 17h35min,prophaseat18h 5min,pro-metaphase at18h 10min,a metaphase-like stageat 18h 15min,anaphasetotelophaseat 18h 40minto 18h 45min,
interphase at 19h 10min, multinucleated G1 (2n) stage at 21h 50min to 37h 30min, and induction of cell death at 40h 50min to 46h 40min as observed by ﬂuorescence
video microscopy. (d) The amount of giant interphase nucleus and abnormal metaphase chromosomes observed in HN2-treated irs1SF cells decreased following equitoxic
HN2treatment.DAPI-stainedinvertedﬂuorescenceimagesofinterphasenucleusandmetaphasechromosomesofuntreatedandHN2(0.3mM)-treatedirs1SFcellsat48and
72h. Images were captured at the same magniﬁcation (objective, 100 10)
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Cell Death and Diseasebetween 48 and 72h following equitoxic HN2 treatment
(Supplementary Table S1 and Supplementary Figure S9).
Although both wild-type and XRCC3-deﬁcient cells under-
went apoptosis at similar time points (Figure 3 and Supple-
mentary Figure S7), XRCC3-deﬁcient cells showed less
incomplete cytokinesis, with relatively normal cell division.
We therefore investigated the chromosomal status in HN2-
treated, XRCC3-deﬁcient cells. Giant interphase nuclei
were not observed in XRCC3-deﬁcient cells at 48 and 72h
following HN2 treatment (Figure 6d). Moreover, chromosomal
abnormalities were signiﬁcantly decreased in XRCC3-
deﬁcient cells as compared with wild-type cells (Figures 5a
and 6d). Therefore, although both cell types undergo the
same amount of cell death through apoptosis and at similar
time points, less giant nuclei, chromosomal abnormalities,
and ampliﬁcations were observed in XRCC3-deﬁcient cells
as compared with wild-type cells.
Discussion
DNA ICL agents are widely used in cancer chemotherapy;
however, an emergence of acquired drug resistance, due at
least partly to ICL repair, is a major clinical problem.
6,7 In this
study, we have investigated cell death resulting from ICL in
mammalian cells, and a connection between cell death and
ICL repair associated with prolonged G2 arrest and incom-
plete cytokinesis has been indicated. Cellular fate following
ICL damage was revealed by using time-lapse video micro-
scopy, and the mechanism of ICL-induced cell death was
conﬁrmed as p53-independent apoptosis. The timing of cell
death suggests that it is induced after an attempt to repair the
ICL damage. Moreover, the trigger of cell death was initiated
after a failure of cytokinesis, associated with chromosome
abnormalities resulting from incomplete or inappropriate ICL
repair. By contrast, an HR repair-deﬁcient cell line showed
diminishedG2arrest,reducedgiantcellformation,andalower
frequency of incomplete cytokinesis. Collectively, our results
illustrate the coordination of ICL-induced cellular responses,
including cell-cycle arrest, DNA damage repair, and cell
death.
An investigation of the relationship between repair of DNA
ICL damage, cell-cycle response, and cell death enabled the
identiﬁcation of a link between HR repair and ICL-induced G2
arrest in mammalian cells. ICLs are most critical in the
S-phase of proliferating cells
32 and are processed through an
unhooking of ICLs and subsequent HR in the late S-to-G2
phases.
2,17 In agreement, our results demonstrated the
hypersensitivity of ERCC1- and XRCC3-deﬁcient cells to
HN2 as determined by a colony formation assay. Moreover,
the clonogenic cell-cycle analyses demonstrated ICL dose-
dependentcytotoxicityaccompaniedbyinductionofG2arrest,
suggesting a connection between G2 arrest and induction of
cell death. Further investigation revealed that the persistence
of ICLs, rather than the initial amount formed, activated
and maintained G2 arrest for more than 48h in wild-type
cells (Figure 1b).
33 Importantly, XRCC3-deﬁcient cells were
severely impaired in the maintenance of G2 arrest when
compared with the wild-type cells, suggesting that HR repair
contributes to the maintenance of G2 arrest induced by
DNA-cross-linking drugs.
The fate of the ICL damage following a prolonged G2 arrest
is characterised as a multinucleated, tetraploid G1 cell death
associatedwithincompletecytokinesis.ActivationofG2arrest
occursaspartoftherepairprocessofICLdamageinsurviving
cells,
19andalsooccursaspartoftheprocessthatleadstocell
death. Cell death following damage-induced G2 arrest has
been reported to occur in the G2,
20 M,
21 or the subsequent
G1/S phases.
12 In the current study, ICL-damaged cells
showed transient mitosis and a novel giant cell death in the
tetraploid G1 phase following the prolonged G2 arrest. This
observationhighlightstheimportanceofreal-timeobservation
using time-lapse video microscopy rather than just a single
time point analysis, which can often result in the misinter-
pretation of cell-cycle transition events. Interestingly, this
‘giant’ cell death was not observed in XRCC3-defective cells,
suggesting that ICL repair, especially by HR, participates not
only in the maintenance of G2 arrest, but also in ICL-induced
‘giant’ cell death.
A comprehensive investigation into the mechanism of
ICL-induced cell death was conducted. Cell death can
occur as a result of multiple processes, including apoptosis,
necrosis, mitotic catastrophe, and apoptotic-like cell
death,
20,21 and can be determined by morphological and
biochemical changes. Previous studies in mouse embryonic
ﬁbroblasts have indicated that alkylation DNA damage (both
monofunctional and bifunctional) stimulates a regulated form
of necrotic cell death independent of p53.
34 The ICL-induced
tetraploid G1 cell death observed in the current study is
associated with several hallmarks of apoptotic cell death
determined by four independent criteria: membrane PS
externalisation, mitochondrial permeability, activation of
caspases, and elevated levels of a sub-G1 phase fraction.
HN2-induced ICLs form rapidly in cells, reaching a peak by
1h.
2 The timing of cell death after drug treatment was 24h
onwardsand occurs after G2 arrest, suggesting that cell death
is initiated after an attempt at ICL damage repair. Whereas
wild-type cells showed an induction of apoptosis concomitant
with prolonged G2 arrest in tetraploid (4n) cells, XRCC3-
deﬁcient cells showed an induction of apoptosis after an
impairedG2arrestindiploid(2n)cells.Itisnoteworthythatthis
type of cell death following prolonged G2 arrest was only
induced by the bifunctional alkylating agent HN2 and not by
the monofunctional agent HN1 at equitoxic drug concentra-
tions, suggesting that DNA ICLs and their processing are
critical for this novel apoptotic cell death.
Wild-type cells following cross-linking drug treatment
possess ‘giant’ nuclei with gross chromosomal abnormalities.
Bycontrast, XRCC3-deﬁcient cells at equitoxic doses showed
diminishedformationof‘giant’nuclei,withfewerchromosomal
abnormalities. It is therefore likely that the abnormal chromo-
somes that triggered ‘giant’ cell death resulted from aberrant
repair of ICL damage (e.g. over-processing of ICL damage
repair and/or an excess of recombination events). In CHO
cells, the ICL-induced tetraploid G1 apoptosis was shown to
be independent of p53-family proteins. It is notable that
histone-H2B-GFP-expressing HeLa cells also demonstrated
tetra/octaploid apoptosis following a prolonged cell-cycle
arrest, indicating the occurrence of ‘giant’ cell death after an
attempt to repair the ICL damage in human cancer cells. In
fact, the multinucleated ‘giant’ cell formation and polyploid cell
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35 as well as a
cellular response to various genotoxic stimuli such as UVA
exposure,
36 ionising radiation,
37 and chemotherapy,
38 and
often associated with mutant p53.
39 Overall, our data suggest
a mechanism of ICL-induced cell death in mammalian cells
(Figure 7).
Inconclusion, the results provided heredescribe forthe ﬁrst
time the occurrence of a novel mechanism of cell death
following an attempt to repair ICL damage. Further investiga-
tion regarding the mechanism underlying cell death with
respect to (1) ICL-induced damage-repair pathways in the
regulation of the cell cycle; (2) induction of cell death following
repair of ICL-induced damage; and (3) chromosomal dyna-
mics during incomplete cytokinesis will further our under-
standing of the ICL-induced apoptotic cell death of cancer
cells following chemotherapy. This may lead to strategies to
eliminate cells that are tolerant or acquire resistance to
conventional chemotherapy, and may enhance the therapeu-
tic index in combination with newly developed antitumor
agents and ultimately lead to new therapeutic strategies for
the treatment of cancer.
Materials and Methods
Cell lines and culture conditions. Cells were obtained from the
departmental cell bank, unless otherwise stated. Wild-type, repair-proﬁcient
(AA8), XPG-deﬁcient (UV135), ERCC1-deﬁcient (UV96), XRCC3-deﬁcient
(irs1SF) CHO cell lines were obtained from the departmental cell bank (Cancer
Research UK Drug-DNA Interactions Research Group, London, UK). HeLa, the
humancervixcancercellline,waspurchasedfromCancerResearchUKcellculture
department (London, UK). The histone-H2B-GFP HeLa cell line was obtained from
G Wahl (Salk Institute, La Jolla, CA, USA). Histone-H2B-GFP AA8, histone-H2B-
GFPirs1SFanddn-p53AA8weregeneratedforthisstudy.TheCHOcelllineswere
grown in Ham F12 nutrient medium (Sigma, Poole, UK). HeLa cells were grown in
DMEM high-glucose medium (Autogen Bioclear, Calne, UK). These media were
supplemented with 10% foetal bovine serum (FBS), 2mM glutamine, and penicillin/
streptomycin at 371C in a humidiﬁed atmosphere containing 5% CO2. In addition,
DMEM medium for culturing the H2B-GFP HeLa cells was supplemented with
blasticidin (Invitrogen-Autogen Bioclear, Calne, UK).
Colony-based survival assay. Three hundred cells were plated onto petri
dishes (100mm) 24h prior to HN2 treatment. Drug dilutions prepared fresh prior to
the treatment and cells were treated in serum-free medium for 1h then replaced in
full medium. After 10–14 days, colonies were stained with 1% methylene blue and
dried overnight. Colonies containing more than approximately 50 cells were
counted.
Cytotoxicity assay. Cell proliferation was assessed by using the sulpho-
rhodamine-B (SRB) assay as described previously.
2
Cell-cycle analysis. Cells were harvested by 5ml of trypsin EDTA (Autogen
Bioclear) after HN2 drug treatment and washed in PBS (Sigma), then ﬁxed in ice-
cold 70% ethanol with gentle vortexing. After a minimum of 30min at 41C, the cells
were washed twice in PBS and resuspended in 100ml of 100mg/ml ribonuclease
(Sigma) and 400ml propidium iodide (PI) (50mg/ml) (Sigma). After incubation for
30min, samples were analysed by using a FACSCalibur (BD BioSciences, San
Jose, CA, USA), with PI ﬂuorescence being measured above 670nm. Cell doublets
and apoptotic cells were excluded from analysis.
BrdU cell-cycle analysis. Prior to drug treatment, cells were treated with
10mM BrdU (Sigma) for 30min in serum-containing medium. The cells were
washed twice with free medium followed by drug treatment for 1h in serum-free
medium. The cells were grown in non-drug-containing medium until an appropriate
time course. After harvesting, the cells were ﬁxed in ice-cold 70% ethanol and kept
at 41C for at least 30min before further processing. After washing, the cells were
treated with 1.5ml of 2M hydrochloric acid and incubated 30min at room
temperature. A 0.5-ml volume of PBS was added and acid was spun off at 2000
r.p.m.followedbywashingin0.5mlofPBSandin0.5mlofPBS-T(PBS,0.1%BSA,
Figure7 MechanismofcelldeathresultingfromDNAICLsinmammaliancells.ICL-damagedcellsundergocelldeaththroughapoptosisasaresultofpersistenceofICLs
inG1, collapseof the stalledreplication fork in S, inefﬁcient or excessICLrepair in G2, mitoticcatastrophe or incompletecytokinesisin M, and multi-nucleation in the tetraploid
G1 phase. By contrast, ICL-damaged cells may survive after ICL removal in G1, translesion synthesis (TLS) in S, efﬁcient ICL repair involving HR in G2, mitotic slippage in M,
polyploidy in the tetraploid G1 phase, and after endoreduplication. The pathway indicates by arrows is the one elucidated in this study, and the pathways indicated by dotted
arrows are the ones proposed in previous studies
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Cell Death and Disease0.2% Tween-20, pH 7.4). A 2-ml volume of anti-BrdU antibody (BD BioSciences,
Oxford, UK) was added directly to the cell pellet and incubated for 15min at room
temperature and samples were washed twice in PBS-T. Then the samples were
stained with 50ml of FITC-conjugated rabbit anti-mouse secondary antibody (Dako,
Ely, UK)ata 1 in100 dilutionfor15min at roomtemperatureandwashedinPBS.A
50-ml volume of RNase (100mg/ml) (Sigma) and 300–400ml of PI (50mg/ml) were
added just before analysis. Samples were analysed on a FACSCalibur (BD
BioSciences). Cell doublets and debris were excluded and FITC ﬂuorescence was
measured between 515 and 545nm, and PI ﬂuorescence above 670nm.
Cell sorting and survival assay. Cell sorting was used to select cells
for the clonogenic survival assay. Cells were harvested by 5ml of trypsin EDTA
while in exponential growth. To stain cellular DNA, 10mg/ml Hoechst-33342 (bis-
benzamide;Sigma)wasaddedandincubatedat371Cfor1htogetherwithdifferent
concentrations of HN2. After the treatment, the cells were sorted depending on the
cell-cycle population (G1 and G2) into culture medium based on cell integrity
(forward versus side scatter) and DNA proﬁle (Hoechst-33342 staining) by using a
FACSVantage(BDBioSciences)cellsorter.Forclonogenicassays,300–5000cells
were sorted per T25 ﬂask depending on the expected surviving fraction after
HN2 treatment to keep the number of colonies per ﬂask at approximately 200.
Three replicates were used at each dose in each experiment so at least 900 cells
wereassessedateachdosepoint.After7–10daysofincubationat371C,theﬂasks
were stained with crystal violet (1%) and colonies of greater than 50 cells were
counted manually.
Phase-contrast, time-lapse video microscopy. Cells were plated on
35mm petri dishes 24h prior to drug treatment. The drug-containing dishes were
washed and replaced with full medium and placed onto the video camera chamber
in a humidiﬁed atmosphere supplied with 5% CO2 at 371C. Images were captured
every 5–10min using  10 to  20 objective lenses of an Olympus inverted
microscope. Phase-contrast images were acquired by using the Kinetic Imaging
software connected to a Sony CCD-IRS camera, which also controlled the shutters
and the ﬁlter wheels to limit light exposure.
Fluorescence video microscopy. For monitoring living cell cultures,
5 10
4cellswereplatedonto35mmglass-bottomculturedishes(MatTekCorporation,
Ashland,MA,USA)24hpriortoanydrugtreatment.Histone-H2B-GFP-expressingAA8
andirs1SF cells weretreated with HN2for 1h inaphenol red-freeand serum-freeHAM
F12 medium (Cancer Research UK cell culture department). After the treatment, the
drug-containing media were discarded and cells were washed with a phenol red-free,
serum-free HAM F12 medium, and then the cells were incubated in a phenol red-free
HAM F12 medium supplemented with 10% FBS and 2mM glutamine. For image
acquisition, the culture dishes were kept in a special chamber, which was kept at 371C
in a humidiﬁed atmosphere containing 5% CO2. Phase-contrast images of cells and/or
epiﬂuorescence images of cell nuclei were acquired on an Axiovert TV 135 microscope
(Carl Zeiss, Maple Grove, MN, USA) equipped with a  63 NA 1.4 objective lens and
an Orca ER CCD camera (Hamamatsu, Photonics K.K., Hamamatsu, Japan) by using
Acquisition Manager (Kinetic Imaging, Liverpool, UK).
Cell membrane analysis(Annexin-Vversus PI). Cells were treatedwith
drugfor1hinaserum-freemedium.Afterthedrugtreatment,thecellswerewashed
twice with serum-free medium. Thereafter, the cells were grown in non-drug-
containing medium for the appropriate time period. After harvesting, both ﬂoating
cells and adherent cells were collected and resuspended in 0.5ml of Annexin
binding buffer (10mM HEPES/NaOH (pH 7.4), 140mM NaCl, 2.5mM CaCl2)
(Pharmingen, San Diego, CA, USA) and 3ml of Annexin-V–FITC were added.
Samples were incubated in the dark at room temperature for 20min and 50mlo fP I
(50mg/ml) were added just before analysis. The samples were analysed by using a
FACSCalibur (BD BioSciences), with FITC ﬂuorescence being measured between
515 and 545nm, and PI ﬂuorescence being measured above 670nm.
Mitochondrialpermeabilisationassay. Duringapoptosisthereisoftena
collapse of mitochondrial membrane potential. Laser Dye Styryl-751 (LDS-751)
stains activate mitochondria and can be detected by ﬂow cytometry.
40 Cells were
treated with drug for 1h in serum-free medium. After the drug treatment, the cells
were washed twice with serum-free medium. Thereafter, the cells were grown in
non-drug-containing medium for the appropriate time course. After harvesting, both
ﬂoating and adherent cells were collected and resuspended in 0.5ml of PBS and
LDS-751 (Exciton, Dayton, OH, USA) to a ﬁnal concentration of 100nM and
incubated at room temperature for 20min, and before analysis 10ml of TO-PRO-3
iodide (1nM; Molecular Probes, Eugene, OR, USA) were added. Samples were
analysed on a FACSCalibur (BD BioSciences), with LDS-751 being excited by a
488-nm laser and the emitted ﬂuorescence measured between 560 and 600nm.
TO-PRO-3 was excited by a 633-nm laser and the emitted ﬂuorescence was
collected with a 660/16-nm band-pass ﬁlter.
Sub-G1 analysis. Cells were treated with drug for 1h in serum-free medium.
After the drug treatment, the cells were washed twice with serum-free medium.
Thereafter, the cells were grown in non-drug-containing medium for the appropriate
time course. After harvesting, both ﬂoating and adhered cells were collected and
ﬁxedinice-cold70%ethanolwithgentlevortexingandkeptforaminimumof30min
at 41C. Samples were washed twice in phosphate-citrate buffer (0.2M Na2HPO4,
0.1M citric acid, pH 7.8) and resuspended in 100ml of RNase (100mg/ml) and
400ml of PI (50mg/ml). After incubation for 30min, the samples were analysed by
using a FACSCalibur (BD BioSciences), with PI ﬂuorescence being measured
above 670nm. Cell doublets and aggregates were excluded from analysis.
Activation of caspase-3 determined by western blotting. Cell
samples were prepared as described previously.
27 Brieﬂy, Cells were washed with
PBS and lysed in ice-cold NP-40 blase buffer (2% NP-40, 2mM NaO4Va, 50mM
NaF, 20mg/ml Apro, 20mg/ml leupeptine, 20mg/ml bensamidine). Total cellular
proteins (10–20mg) were boiled in 4  sample buffer (250mM Tris-HCl (pH 6.8),
8% SDS, 40% glycerol, 20% b-mercaptoethanol, 1mg/10ml bromophenol blue)
and separated on 12–15% SDS polyacrylamide gels and blotted onto nitro-
cellulose overnight. After the transfer, the membranes were washed in PBS and
PBS-T, and incubated with a cleaved caspase-3 rabbit monoclonal antibody (Cell
SignalingTechnology,Beverly,MA,USA),followedbysubsequentincubationwitha
horseradish peroxidase-conjugated anti-rabbit secondary antibody (Amersham,
Little Chalfont, UK). Immunoreactive bands were visualised by enhanced
chemiluminescence (Amersham).
Metaphase chromosome and interphase nucleus preparation.
After 1h of HN2 treatment, cells were incubated in medium containing 0.05mg/ml
colcemid (Gibco, Grand Island, NY, USA) at 371C for 1h. The cells were treated
with a hypotonic solution of 0.075M KCl for 15min at room temperature. The cells
were then ﬁxed three times with methanol/acetic acid (3:1) and metaphase
preparations were made. The slides were mounted in a DAPI/Antifade mounting
medium (Abbott Laboratories, Kent, UK). Spectral images were captured by using
a CCD camera attached to AX10 plan microscope (Zeiss, Birmingham, UK).
Production of histone-H2B-GFP and dn-p53-expressing cells.
H2B-GFP expression pCLNR-H2BG
41 and a dn-p53, pBabepuro-p53
175 plasmids
were transfected together with a packaging pHIT60 carrying MLV gag-pol, and an
envelopeglycoproteinexpressionplasmid,pMD-G,encodesthevesicularstomatitis
virus G-protein (VSV-G) under the control of the hCMV promoter. Transfection of
293T cells was conducted by using Lipofectamine (Invitrogen, Paisley, UK) as
described in the manufacturer’s instructions. CHO cells were plated at 1 10
5 cells
per well in 24-well plates 24h before infection. On the day of infection, the ﬁltered
supernatant was serially diluted in OptiMEM and added to the wells in the presence
of 1 10
5mg/ml polybrene (hexadimethrine bromide, Sigma). The cells were
incubated overnight at 371C. The virus was then washed off the cells and replaced
with HAM F12 containing 10% FCS. Cells expressing H2B-GFP were sorted by
using a FACS Vantage (BD BioSciences). The cells were then cultured and
maintained in HAM F12 medium. The dn-p53-expressing cells were selected by
using a HAM F12 medium containing 10mg/ml puromycin for 2 weeks.
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